Novel poly(ethylene 2,5-furandicarboxylate) PEF nonwovens were produced by solution electrospinning and further modification. To improve the wettability of the hydrophobic nonwovens with water, they were treated with sodium hydroxide. Cytotoxicity tests carried out with human keratinocytes confirmed that the nonwovens did not have a toxic effect on healthy cells. The hydrophilicity of the sodium hydroxide treated nonwoven favored the adherence of the cells and their growth. In turn, the two-step modification of the nonwovens by reactions with (3-mercaptopropyl)methyldimethoxysilane and silver nitrate permitted to deposit silver particles on the fiber surfaces. The bacteria growth inhibition zones around the tested specimens were observed evidencing their antibacterial activity against Escherichia coli and Staphylococcus aureus.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.colsurfb.2023.113609DOI Listing

Publication Analysis

Top Keywords

polyethylene 25-furandicarboxylate
8
sodium hydroxide
8
cytotoxicity studies
4
studies antibacterial
4
antibacterial modification
4
modification polyethylene
4
25-furandicarboxylate nonwoven
4
nonwoven novel
4
novel polyethylene
4
25-furandicarboxylate pef
4

Similar Publications

Particle elasticity has widely been established to substantially influence immune cell clearance and circulation time of vascular-targeted carriers (VTCs). However, prior studies have primarily investigated interactions with macrophages, monocytic cell lines, and in vivo murine models. Interactions between particles and human neutrophils remain largely unexplored, although they represent a critical aspect of VTC performance.

View Article and Find Full Text PDF

It has been shown that depositing ketoprofen as thin films on glass substrates has a stabilizing effect on the amorphous state of ketoprofen. Polyethylene glycol ( = 6000 g/mol) was mixed with ketoprofen in a wide range of concentrations. Amorphous thin films were prepared by spin coating and subjected to storage conditions with different levels of relative humidity.

View Article and Find Full Text PDF

The nanoengager strategy, which enhances receptor signaling responsiveness through a multivalent ligand binding mode, offers a promising approach for improving immune cell redirecting therapy. Increasing nanomaterial platforms have been developed for constructing more flexible and multifunctional nanoengagers, but the different mediating mechanisms from their multivalent nanostructures, compared to original monomolecule engagers, have rarely been discussed. Here, we constructed dual-specificity T cell nanoengagers (TNEs) targeting CD3 and PDL1 receptors based on a polyethylene glycol--polylactic acid (PEG--PLA)-assembled nanoparticle and specifically studied the impact of surface antibody valences on their functional mechanisms, thereby enhancing the structural advantages of TNEs against solid tumors.

View Article and Find Full Text PDF

Aim: The aim of this study was to compare the marginal accuracy of polyetheretherketone (PEEK) and zirconia copings fabricated using computer-aided design/computer-aided manufacturing (CAD/CAM) technology, and to assess the impact of their material properties on accuracy when produced with a 4-axis milling system under controlled conditions.

Settings And Design: The study employed an in vitro design with a stainless steel die model featuring a 6 mm axial wall height, a 6-degree total occlusal convergence, and a radial shoulder finish line.

Materials And Methods: Thirty stone dies were created from silicone impressions of the metal die and poured using type-IV dental stone.

View Article and Find Full Text PDF

pH-Responsive Polyethylene Glycol Engagers for Enhanced Brain Delivery of PEGylated Nanomedicine to Treat Glioblastoma.

ACS Nano

January 2025

Department of Biological Science and Technology, Center for Intelligent Drug Systems and Smart Bio-devices (IDS2B), National Yang Ming Chiao Tung University, Hsinchu 300, Taiwan.

The blood-brain barrier (BBB) remains a major obstacle for effective delivery of therapeutics to treat central nervous system (CNS) disorders. Although transferrin receptor (TfR)-mediated transcytosis is widely employed for brain drug delivery, the inefficient release of therapeutic payload hinders their efficacy from crossing the BBB. Here, we developed a pH-responsive anti-polyethylene glycol (PEG) × anti-TfR bispecific antibody (pH-PEG engager) that can complex with PEGylated nanomedicine at physiological pH to trigger TfR-mediated transcytosis in the brain microvascular endothelial cells, while rapidly dissociating from PEGylated nanomedicine at acidic endosomes for efficient release of PEGylated nanomedicine to cross the BBB.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!